743 related articles for article (PubMed ID: 17826898)
1. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
Esplugas S; Bila DM; Krause LG; Dezotti M
J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
[TBL] [Abstract][Full Text] [Related]
2. Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health.
Rahman MF; Yanful EK; Jasim SY
J Water Health; 2009 Jun; 7(2):224-43. PubMed ID: 19240349
[TBL] [Abstract][Full Text] [Related]
3. Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment plant.
Padhye LP; Yao H; Kung'u FT; Huang CH
Water Res; 2014 Mar; 51():266-76. PubMed ID: 24262763
[TBL] [Abstract][Full Text] [Related]
4. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents.
Yang B; Ying GG; Zhao JL; Liu S; Zhou LJ; Chen F
Water Res; 2012 May; 46(7):2194-204. PubMed ID: 22342241
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of a pilot-scale nonthermal plasma advanced oxidation process for trace organic compound degradation.
Gerrity D; Stanford BD; Trenholm RA; Snyder SA
Water Res; 2010 Jan; 44(2):493-504. PubMed ID: 19822343
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
Boyd GR; Reemtsma H; Grimm DA; Mitra S
Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
[TBL] [Abstract][Full Text] [Related]
7. Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment.
Broséus R; Vincent S; Aboulfadl K; Daneshvar A; Sauvé S; Barbeau B; Prévost M
Water Res; 2009 Oct; 43(18):4707-17. PubMed ID: 19695660
[TBL] [Abstract][Full Text] [Related]
8. Removing emerging contaminants.
Christen K
Environ Sci Technol; 2008 Jan; 42(1):6-7. PubMed ID: 18350867
[No Abstract] [Full Text] [Related]
9. Occurrence and treatment trials of endocrine disrupting chemicals (EDCs) in wastewaters.
Jiang JQ; Yin Q; Zhou JL; Pearce P
Chemosphere; 2005 Oct; 61(4):544-50. PubMed ID: 16202808
[TBL] [Abstract][Full Text] [Related]
10. The methods of identification, analysis, and removal of endocrine disrupting compounds (EDCs) in water.
Chang HS; Choo KH; Lee B; Choi SJ
J Hazard Mater; 2009 Dec; 172(1):1-12. PubMed ID: 19632774
[TBL] [Abstract][Full Text] [Related]
11. A QSAR-like analysis of the adsorption of endocrine disrupting compounds, pharmaceuticals, and personal care products on modified activated carbons.
Redding AM; Cannon FS; Snyder SA; Vanderford BJ
Water Res; 2009 Aug; 43(15):3849-61. PubMed ID: 19592065
[TBL] [Abstract][Full Text] [Related]
12. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
[TBL] [Abstract][Full Text] [Related]
13. Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan.
Wu Q; Shi H; Adams CD; Timmons T; Ma Y
Sci Total Environ; 2012 Nov; 439():18-25. PubMed ID: 23059968
[TBL] [Abstract][Full Text] [Related]
14. Practical overview of analytical methods for endocrine-disrupting compounds, pharmaceuticals and personal care products in water and wastewater.
Comerton AM; Andrews RC; Bagley DM
Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3923-39. PubMed ID: 19736228
[TBL] [Abstract][Full Text] [Related]
15. Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment - physical means, biodegradation, and chemical advanced oxidation: a review.
Liu ZH; Kanjo Y; Mizutani S
Sci Total Environ; 2009 Jan; 407(2):731-48. PubMed ID: 18992918
[TBL] [Abstract][Full Text] [Related]
16. Rejection of pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) by low pressure reverse osmosis membranes.
Ozaki H; Ikejima N; Shimizu Y; Fukami K; Taniguchi S; Takanami R; Giri RR; Matsui S
Water Sci Technol; 2008; 58(1):73-81. PubMed ID: 18653939
[TBL] [Abstract][Full Text] [Related]
17. Ozonation of estrogenic chemicals in biologically treated sewage.
Hansen KM; Andersen HR; Ledin A
Water Sci Technol; 2010; 62(3):649-57. PubMed ID: 20706012
[TBL] [Abstract][Full Text] [Related]
18. Removal of endocrine disrupting compounds from wastewater treatment plant effluents by means of advanced oxidation.
Bertanza G; Pedrazzani R; Zambarda V; Grande MD; Icarelli F; Baldassarre L
Water Sci Technol; 2010; 61(7):1663-71. PubMed ID: 20371923
[TBL] [Abstract][Full Text] [Related]
19. Determination of acidic pharmaceuticals and potential endocrine disrupting compounds in wastewaters and spring waters by selective elution and analysis by gas chromatography-mass spectrometry.
Gibson R; Becerril-Bravo E; Silva-Castro V; Jiménez B
J Chromatogr A; 2007 Oct; 1169(1-2):31-9. PubMed ID: 17884063
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA.
Boyd GR; Palmeri JM; Zhang S; Grimm DA
Sci Total Environ; 2004 Oct; 333(1-3):137-48. PubMed ID: 15364525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
